Analyst consensus rating

MediciNova Analyst Rating: Strong Buy

Direct answer

MediciNova's consensus rating is Strong Buy.

4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.25.
Forecast evidence checked November 19, 2026.

Get free MediciNova email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$1.27
Average price target
$8.25
High price target
$11.00
Low price target
$6.00
Low target gap
+372.4%
Target upside
+549.6%
High target gap
+766.1%
Target range width
393.7%
Consensus rating
Strong Buy
Analysts
4
Evidence date
November 19, 2026
Valid through
November 26, 2026

Read the frequently asked questions.

What is the analyst consensus rating for MediciNova?

MediciNova has a verified Strong Buy consensus. The same dataset has an average price target of $8.25.

How far are MediciNova's low and high targets from the recorded price?

The low target implies +372.4%, while the high target implies +766.1%.

How many analysts are included in MediciNova's consensus?

The verified consensus includes 4 analysts.

How is MediciNova's target upside or downside calculated?

The average target of $8.25 is divided by the recorded price of $1.27, then one is subtracted to produce +549.6%. This does not guarantee a future return.

When was MediciNova's analyst forecast verified?

The data was verified on 2026-11-19. The dataset is valid through 2026-11-26.